Essential Evidence-Based Psychopharmacology
Herausgeber: Lerer, Bernard; Stein, Dan; Stahl, Stephen
Essential Evidence-Based Psychopharmacology
Herausgeber: Lerer, Bernard; Stein, Dan; Stahl, Stephen
- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
An evidence-based approach to psychopharmacology addressing the questions of optimal first line interventions, maintenance pharmacotherapy and management of treatment-refractory patients.
An evidence-based approach to psychopharmacology addressing the questions of optimal first line interventions, maintenance pharmacotherapy and management of treatment-refractory patients.
Produktdetails
- Produktdetails
- Verlag: Cambridge University Press
- Seitenzahl: 334
- Erscheinungstermin: 28. März 2013
- Englisch
- Abmessung: 240mm x 161mm x 23mm
- Gewicht: 668g
- ISBN-13: 9781107007956
- ISBN-10: 110700795X
- Artikelnr.: 34541691
- Verlag: Cambridge University Press
- Seitenzahl: 334
- Erscheinungstermin: 28. März 2013
- Englisch
- Abmessung: 240mm x 161mm x 23mm
- Gewicht: 668g
- ISBN-13: 9781107007956
- ISBN-10: 110700795X
- Artikelnr.: 34541691
Preface; Foreword; 1. Evidence-based pharmacotherapy of attention deficit
hyperactivity disorder Brigitte S. Vaughan, John S. March and Christopher
J. Kratochvil; 2. Evidence-based pharmacotherapy of schizophrenia Stefan
Leucht, Stephan Heres, Werner Kissling and John M. Davis; 3. Evidence-based
pharmacotherapy of bipolar disorder Matthew J. Taylor and John R. Geddes;
4. Evidence-based pharmacotherapy of major depressive disorder Jamie M.
Dupuy, Michael J. Ostacher, Jeffrey Huffman, Roy H. Perlis and Andrew A.
Nierenberg; 5. Evidence-based pharmacotherapy of panic disorder Neeltje M.
Batelaan, Anton J. L. M. Van Balkom and Dan J. Stein; 6. Evidence-based
pharmacotherapy of social anxiety disorder Carlos Blanco, Laura B. Bragdon,
Franklin R. Schneier and Michael R. Liebowitz; 7. Evidence-based
pharmacotherapy of generalised anxiety disorder David S. Baldwin, Sarah
Waldman and Christer Allgulander; 8. Evidence-based pharmacotherapy of
obsessive-compulsive disorder Naomi A. Fineberg, Angus Brown and Ilenia
Pampaloni; 9. Evidence-based pharmacotherapy of posttraumatic stress
disorder Jonathan C. Ipser and Dan J. Stein; 10. Evidence-based
pharmacotherapy of eating disorders Martine F. Flament, Hany Bissada and
Wendy Spettigue; 11. Evidence-based pharmacotherapy of nicotine and alcohol
dependence Wim van den Brink; 12. Evidence-based pharmacotherapy of illicit
substance use disorders Wim van den Brink; 13. Evidence-based
pharmacotherapy of Alzheimer's disease Darren Cotterell and Martin Brown;
14. Evidence-based pharmacotherapy of personality disorders Luis H. Ripoll,
Joseph Triebwasser and Larry J. Siever; Index.
hyperactivity disorder Brigitte S. Vaughan, John S. March and Christopher
J. Kratochvil; 2. Evidence-based pharmacotherapy of schizophrenia Stefan
Leucht, Stephan Heres, Werner Kissling and John M. Davis; 3. Evidence-based
pharmacotherapy of bipolar disorder Matthew J. Taylor and John R. Geddes;
4. Evidence-based pharmacotherapy of major depressive disorder Jamie M.
Dupuy, Michael J. Ostacher, Jeffrey Huffman, Roy H. Perlis and Andrew A.
Nierenberg; 5. Evidence-based pharmacotherapy of panic disorder Neeltje M.
Batelaan, Anton J. L. M. Van Balkom and Dan J. Stein; 6. Evidence-based
pharmacotherapy of social anxiety disorder Carlos Blanco, Laura B. Bragdon,
Franklin R. Schneier and Michael R. Liebowitz; 7. Evidence-based
pharmacotherapy of generalised anxiety disorder David S. Baldwin, Sarah
Waldman and Christer Allgulander; 8. Evidence-based pharmacotherapy of
obsessive-compulsive disorder Naomi A. Fineberg, Angus Brown and Ilenia
Pampaloni; 9. Evidence-based pharmacotherapy of posttraumatic stress
disorder Jonathan C. Ipser and Dan J. Stein; 10. Evidence-based
pharmacotherapy of eating disorders Martine F. Flament, Hany Bissada and
Wendy Spettigue; 11. Evidence-based pharmacotherapy of nicotine and alcohol
dependence Wim van den Brink; 12. Evidence-based pharmacotherapy of illicit
substance use disorders Wim van den Brink; 13. Evidence-based
pharmacotherapy of Alzheimer's disease Darren Cotterell and Martin Brown;
14. Evidence-based pharmacotherapy of personality disorders Luis H. Ripoll,
Joseph Triebwasser and Larry J. Siever; Index.
Preface; Foreword; 1. Evidence-based pharmacotherapy of attention deficit
hyperactivity disorder Brigitte S. Vaughan, John S. March and Christopher
J. Kratochvil; 2. Evidence-based pharmacotherapy of schizophrenia Stefan
Leucht, Stephan Heres, Werner Kissling and John M. Davis; 3. Evidence-based
pharmacotherapy of bipolar disorder Matthew J. Taylor and John R. Geddes;
4. Evidence-based pharmacotherapy of major depressive disorder Jamie M.
Dupuy, Michael J. Ostacher, Jeffrey Huffman, Roy H. Perlis and Andrew A.
Nierenberg; 5. Evidence-based pharmacotherapy of panic disorder Neeltje M.
Batelaan, Anton J. L. M. Van Balkom and Dan J. Stein; 6. Evidence-based
pharmacotherapy of social anxiety disorder Carlos Blanco, Laura B. Bragdon,
Franklin R. Schneier and Michael R. Liebowitz; 7. Evidence-based
pharmacotherapy of generalised anxiety disorder David S. Baldwin, Sarah
Waldman and Christer Allgulander; 8. Evidence-based pharmacotherapy of
obsessive-compulsive disorder Naomi A. Fineberg, Angus Brown and Ilenia
Pampaloni; 9. Evidence-based pharmacotherapy of posttraumatic stress
disorder Jonathan C. Ipser and Dan J. Stein; 10. Evidence-based
pharmacotherapy of eating disorders Martine F. Flament, Hany Bissada and
Wendy Spettigue; 11. Evidence-based pharmacotherapy of nicotine and alcohol
dependence Wim van den Brink; 12. Evidence-based pharmacotherapy of illicit
substance use disorders Wim van den Brink; 13. Evidence-based
pharmacotherapy of Alzheimer's disease Darren Cotterell and Martin Brown;
14. Evidence-based pharmacotherapy of personality disorders Luis H. Ripoll,
Joseph Triebwasser and Larry J. Siever; Index.
hyperactivity disorder Brigitte S. Vaughan, John S. March and Christopher
J. Kratochvil; 2. Evidence-based pharmacotherapy of schizophrenia Stefan
Leucht, Stephan Heres, Werner Kissling and John M. Davis; 3. Evidence-based
pharmacotherapy of bipolar disorder Matthew J. Taylor and John R. Geddes;
4. Evidence-based pharmacotherapy of major depressive disorder Jamie M.
Dupuy, Michael J. Ostacher, Jeffrey Huffman, Roy H. Perlis and Andrew A.
Nierenberg; 5. Evidence-based pharmacotherapy of panic disorder Neeltje M.
Batelaan, Anton J. L. M. Van Balkom and Dan J. Stein; 6. Evidence-based
pharmacotherapy of social anxiety disorder Carlos Blanco, Laura B. Bragdon,
Franklin R. Schneier and Michael R. Liebowitz; 7. Evidence-based
pharmacotherapy of generalised anxiety disorder David S. Baldwin, Sarah
Waldman and Christer Allgulander; 8. Evidence-based pharmacotherapy of
obsessive-compulsive disorder Naomi A. Fineberg, Angus Brown and Ilenia
Pampaloni; 9. Evidence-based pharmacotherapy of posttraumatic stress
disorder Jonathan C. Ipser and Dan J. Stein; 10. Evidence-based
pharmacotherapy of eating disorders Martine F. Flament, Hany Bissada and
Wendy Spettigue; 11. Evidence-based pharmacotherapy of nicotine and alcohol
dependence Wim van den Brink; 12. Evidence-based pharmacotherapy of illicit
substance use disorders Wim van den Brink; 13. Evidence-based
pharmacotherapy of Alzheimer's disease Darren Cotterell and Martin Brown;
14. Evidence-based pharmacotherapy of personality disorders Luis H. Ripoll,
Joseph Triebwasser and Larry J. Siever; Index.